DrugPatentWatch Database Preview
TRULANCE Drug Profile
Try a free trial
See Plans and Pricing
Which patents cover Trulance, and what generic alternatives are available?
Trulance is a drug marketed by Salix and is included in one NDA. There are eight patents protecting this drug.
This drug has fifty-six patent family members in fourteen countries.
The generic ingredient in TRULANCE is plecanatide. Two suppliers are listed for this compound. Additional details are available on the plecanatide profile page.
Summary for TRULANCE
| International Patents: | 56 |
| US Patents: | 8 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 2 |
| Clinical Trials: | 2 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for TRULANCE |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for TRULANCE |
| DailyMed Link: | TRULANCE at DailyMed |
Generic Entry Opportunity Date for TRULANCE
Generic Entry Date for TRULANCE*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
TABLET;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for TRULANCE
| Drug Class | Guanylate Cyclase-C Agonist |
| Mechanism of Action | Guanylate Cyclase Activators |
Synonyms for TRULANCE
| (3-Glutamic acid(D>E))human uroguanylin (UGN) |
| [3-glutamic acid(D>E)]human uroguanylin |
| 467426-54-6 |
| 7IK8Z952OK |
| CHEMBL2103867 |
| DB13170 |
| DTXSID60196933 |
| GTPL9069 |
| Guanilib |
| PLECANATIDE |
| Plecanatide [USAN:INN] |
| SP-304 |
| UNII-7IK8Z952OK |
US Patents and Regulatory Information for TRULANCE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Salix | TRULANCE | plecanatide | TABLET;ORAL | 208745-001 | Jan 19, 2017 | RX | Yes | Yes | Try a Free Trial | Try a Free Trial | Try a Free Trial | ||||
| Salix | TRULANCE | plecanatide | TABLET;ORAL | 208745-001 | Jan 19, 2017 | RX | Yes | Yes | Try a Free Trial | Try a Free Trial | Y | Try a Free Trial | |||
| Salix | TRULANCE | plecanatide | TABLET;ORAL | 208745-001 | Jan 19, 2017 | RX | Yes | Yes | Try a Free Trial | Try a Free Trial | Try a Free Trial | ||||
| Salix | TRULANCE | plecanatide | TABLET;ORAL | 208745-001 | Jan 19, 2017 | RX | Yes | Yes | Try a Free Trial | Try a Free Trial | Try a Free Trial | ||||
| Salix | TRULANCE | plecanatide | TABLET;ORAL | 208745-001 | Jan 19, 2017 | RX | Yes | Yes | Try a Free Trial | Try a Free Trial | Y | Try a Free Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for TRULANCE
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Eurasian Patent Organization | 201592263 | Try a Free Trial |
| Canada | 2905585 | Try a Free Trial |
| European Patent Office | 3004138 | Try a Free Trial |
| Canada | 2441970 | Try a Free Trial |
| Australia | 2011302006 | Try a Free Trial |
| >Country | >Patent Number | >Estimated Expiration |
